Significance of antinuclear antibodies in primary immune thrombocytopenia: results of the CARMEN registry

Blood Adv. 2020 May 12;4(9):1974-1977. doi: 10.1182/bloodadvances.2020001664.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Antinuclear
  • Autoimmunity
  • Humans
  • Prevalence
  • Prognosis
  • Purpura, Thrombocytopenic, Idiopathic* / diagnosis
  • Purpura, Thrombocytopenic, Idiopathic* / epidemiology
  • Registries

Substances

  • Antibodies, Antinuclear